Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2397
Title: | Complicated pneumonia in children | Authors: | Chang, Anne Bush, A. Zar, H. J. Colin, A. A. de Benedictis, F. M. Kerem, E. |
Issue Date: | 2020 | Source: | 396, (10253), 2020, p. 786-798 | Pages: | 786-798 | Journal: | The Lancet | Abstract: | Complicated community-acquired pneumonia in a previously well child is a severe illness characterised by combinations of local complications (eg, parapneumonic effusion, empyema, necrotising pneumonia, and lung abscess) and systemic complications (eg, bacteraemia, metastatic infection, multiorgan failure, acute respiratory distress syndrome, disseminated intravascular coagulation, and, rarely, death). Complicated community-acquired pneumonia should be suspected in any child with pneumonia not responding to appropriate antibiotic treatment within 48–72 h. Common causative organisms are Streptococcus pneumoniae and Staphylococcus aureus. Patients have initial imaging with chest radiography and ultrasound, which can also be used to assess the lung parenchyma, to identify pleural fluid; CT scanning is not usually indicated. Complicated pneumonia is treated with a prolonged course of intravenous antibiotics, and then oral antibiotics. The initial choice of antibiotic is guided by local microbiological knowledge and by subsequent positive cultures and molecular testing, including on pleural fluid if a drainage procedure is done. Information from pleural space imaging and drainage should guide the decision on whether to administer intrapleural fibrinolytics. Most patients are treated by drainage and more extensive surgery is rarely needed; in any event, in low-income and middle-income countries, resources for extensive surgeries are scarce. The clinical course of complicated community-acquired pneumonia can be prolonged, especially when patients have necrotising pneumonia, but complete recovery is the usual outcome.L20077493962020-09-22 | DOI: | 10.1016/S0140-6736(20)31550-6 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L2007749396&from=exporthttp://dx.doi.org/10.1016/S0140-6736(20)31550-6 | | Keywords: | computer assisted tomography;continuous positive airway pressure;diagnostic imaging;diet therapy;disease course;disseminated intravascular clotting;drug administration route;echography;high flow nasal cannula therapy;human;hyponatremia;immunization;incidence;infection prevention;laboratory test;low income country;lung abscess;lung parenchyma;middle income country;molecular diagnosis;mortality;multiple organ failure;necrotizing pneumonia;pathophysiology;pediatric patient;physiotherapy;pleura effusion;pleura empyema;priority journal;prognosis;prophylaxis;randomized controlled trial (topic);rehydration;respiratory tract infection;review;bacteremia;antibiotic therapy;adult respiratory distress syndrome;urokinase;risk factor;Staphylococcus aureus;Streptococcus pneumoniae;thoracotomy;thorax drainage;thorax radiography;treatment duration;video assisted thoracoscopic surgery;bacterium culture;corticosteroid derivative;acute phase proteinantibiotic agent;placebo;community acquired pneumonia | Type: | Article |
Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.